Building on his lab’s previous success developing bioengineered models of key tissues to study eye disease, the SUNY Upstate researcher will use this grant to investigate the mechanisms that cause glaucoma.
Prior to assuming oversight of the incubator’s operations, with a primary focus on amplifying its impact within the start-up ecosystem, Blake Adair was Vice President of Business Operations at EpiBone, Inc., a prominent player in regenerative medicine.
Research at SUNY produces more than 200 new technologies every year. SUNY TechConnect is the gateway to world-class SUNY discoveries that are available for licensing and other partnership opportunities.